The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis
Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Africa, Asia, Europe, North and South America and Oceania.
The aim of the trial is to evaluate the effect of somatropin (human growth hormone) on
survival (primary end-point; "time to death" and health related quality of life in adult
patients on chronic haemodialysis.